154 Participants Needed

HPV Infections for Oropharyngeal Cancer

Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to determine how often women with throat cancer, or those with a partner who has throat cancer, develop high-risk HPV (human papillomavirus) infections in the anogenital area that could lead to cancer. Participants will fill out surveys, watch a video about HPV vaccination, and provide blood and saliva samples. They are also encouraged to maintain regular cervical screenings and may be referred to a gynecologist if needed. The study seeks women diagnosed with HPV-positive throat cancer or female partners of those diagnosed, who are patients at the Mayo Clinic and can complete the required surveys.

As an unphased trial, this study offers participants the chance to contribute to important research that could enhance understanding and prevention of HPV-related cancers.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

Why are researchers excited about this trial?

Researchers are excited about this trial because it takes a comprehensive approach to understanding HPV's impact on anogenital health in women, especially those connected to oropharyngeal carcinoma cases. Unlike typical treatments that focus on individual symptoms or conditions, this trial combines education, screenings, and biological sample collection to provide a more holistic view of HPV's effects. By integrating educational videos on HPV vaccination and ensuring participants are up to date with cervical and anogenital screenings, this trial aims to improve prevention and early detection strategies, potentially leading to more effective public health interventions.

Who Is on the Research Team?

KM

Kathryn M. Van Abel, M.D.

Principal Investigator

Mayo Clinic in Rochester

Are You a Good Fit for This Trial?

Inclusion Criteria

Female patients with a positive diagnosis of Human Papillomavirus-associated Oropharyngeal Squamous Cell Carcinoma seen at the Mayo Clinic in Rochester.
You are the female partner of a Mayo Clinic patient with positive HPV-associated oropharyngeal squamous cell carcinoma.
Age ≥ 18
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observational

Participants complete surveys, watch an educational video on HPV vaccination, and undergo collection of blood and saliva samples. Patients also undergo cervical screening per standard of care and may receive a referral to gynecology if not up to date on anogenital screening.

Baseline (at enrollment)

Follow-up

Participants are monitored for safety and effectiveness after the observational activities

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Non-Interventional Study

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+